Ahn JS - Search Results

1

The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.

Sung HH, Ahn JS, Kim JJ, Choo SH, Han DH, Lee SW. Sung HH, et al. Among authors: ahn js. Andrology. 2014 Jan;2(1):45-50. doi: 10.1111/j.2047-2927.2013.00155.x. Epub 2013 Nov 6. Andrology. 2014. PMID: 24194017 Free article.

2

Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.

Lee JS, Cho YS, Park EJ, Kim J, Oh WK, Lee HS, Ahn JS. Lee JS, et al. Among authors: ahn js. J Nat Prod. 1998 Jul;61(7):867-71. doi: 10.1021/np970367q. J Nat Prod. 1998. PMID: 9677265

3

Uncarinic acids: phospholipase Cgamma1 inhibitors from hooks of Uncaria rhynchophylla.

Lee JS, Yang MY, Yeo H, Kim J, Lee HS, Ahn JS. Lee JS, et al. Among authors: ahn js. Bioorg Med Chem Lett. 1999 May 17;9(10):1429-32. doi: 10.1016/s0960-894x(99)00211-5. Bioorg Med Chem Lett. 1999. PMID: 10360750

4

Inhibition of phospholipase cgamma1 and cancer cell proliferation by triterpene esters from Uncaria rhynchophylla.

Lee JS, Kim J, Kim BY, Lee HS, Ahn JS, Chang YS. Lee JS, et al. Among authors: ahn js. J Nat Prod. 2000 Jun;63(6):753-6. doi: 10.1021/np990478k. J Nat Prod. 2000. PMID: 10869194

5

Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?

Park BB, Park JO, Kim H, Ahn YC, Choi YS, Kim K, Kim J, Shim YM, Ahn JS, Park K. Park BB, et al. Among authors: ahn js, ahn yc. Lung Cancer. 2006 Sep;53(3):323-30. doi: 10.1016/j.lungcan.2006.05.024. Epub 2006 Jul 17. Lung Cancer. 2006. PMID: 16844258

6

A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management.

Lee HS, Kim ST, Lee J, Choi YS, Han JH, Ahn YC, Lee KS, Ahn JS, Ahn MJ, Kim K, Shim YM, Kim J, Park K. Lee HS, et al. Among authors: ahn js, ahn yc, ahn mj. Br J Cancer. 2007 Jul 2;97(1):22-8. doi: 10.1038/sj.bjc.6603833. Epub 2007 Jun 26. Br J Cancer. 2007. PMID: 17592498 Free PMC article.

7

ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy.

Hwang IG, Ahn MJ, Park BB, Ahn YC, Han J, Lee S, Kim J, Shim YM, Ahn JS, Park K. Hwang IG, et al. Among authors: ahn js, ahn yc, ahn mj. Cancer. 2008 Sep 15;113(6):1379-86. doi: 10.1002/cncr.23693. Cancer. 2008. PMID: 18623378 Free article.

8

Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras.

Kim HS, Park K, Jun HJ, Yi SY, Lee J, Ahn JS, Park YH, Kim S, Lee S, Ahn MJ. Kim HS, et al. Among authors: ahn js, ahn mj. Oncology. 2009;76(4):239-46. doi: 10.1159/000205386. Epub 2009 Feb 25. Oncology. 2009. PMID: 19246948

9

Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.

Park S, Holmes-Tisch AJ, Cho EY, Shim YM, Kim J, Kim HS, Lee J, Park YH, Ahn JS, Park K, Jänne PA, Ahn MJ. Park S, et al. Among authors: ahn js, ahn mj. J Thorac Oncol. 2009 Jul;4(7):809-15. doi: 10.1097/JTO.0b013e3181a94af4. J Thorac Oncol. 2009. PMID: 19487967 Free article.

10

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.

Park YH, Lee S, Cho EY, Choi YL, Lee JE, Nam SJ, Yang JH, Ahn JS, Im YH. Park YH, et al. Among authors: ahn js. Cancer Chemother Pharmacol. 2010 Aug;66(3):507-16. doi: 10.1007/s00280-009-1190-7. Epub 2009 Dec 3. Cancer Chemother Pharmacol. 2010. PMID: 19956951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,460 results

Search Page

Filters